Literature DB >> 3376580

[Cholesterol screening within the scope of preventive strategies].

G Murza1, U Laaser, R Annuss.   

Abstract

The "Consensus-Conference" of the European Atherosclerosis Association held in June 1986, came to an agreement, that all adults with cholesterol levels above 200 mg/dl should receive medical attention. First representative investigations in the Federal Republic of Germany showed that levels below 200 mg/dl are found in less than 30% of persons aged 30 to 59 years. 76% of all patients who where examined didn't know their own cholesterol level. These data verify the urgency of intensive preventive actions. Cholesterol screening without simultaneous supply of information for behaviour modification (especially nutrition education), would be of little use. Therefore in the proposed screening-concept communicative procedures are of great significance. In addition, cooperation between physicians, psychologists, teachers and suitable organisations is necessary.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376580     DOI: 10.1007/bf02084007

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  5 in total

1.  Consensus conference. Lowering blood cholesterol to prevent heart disease.

Authors: 
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

2.  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

3.  Drug information source credibility among junior and senior high school youths.

Authors:  R Dembo; J Schmeidler; D V Babst; D S Lipton
Journal:  Am J Drug Alcohol Abuse       Date:  1977       Impact factor: 3.829

4.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

5.  Population screening for cholesterol determination. A pilot study.

Authors:  E L Wynder; F Field; N J Haley
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.